CCM
PTX

Covington Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Covington Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$3K – 832
2017
Q3 		$3K Buy
+1,000
New +$3.21K ﹤0.01% 680

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Covington Capital Management's PTX Position: Q4 2017 in Review

Covington Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2017, closing a stake of 1,000 shares — an estimated $3K sold.

Covington Capital Management first reported a position in PTX in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 30 funds tracked by Wall St. Rank hold PTX as of Q4 2017.

  • Covington Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Covington Capital Management sold 1,000 Pernix Therapeutics Holdings, Inc. shares in Q4 2017, an estimated $3K.
  • Covington Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2017 and held it in 1 quarter.
  • Covington Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $3K in Q3 2017.
  • 30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2017.

Based on Covington Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.